ShareKUWAIT: The President of the Kuwaiti Association for Nuclear Medicine and Molecular Imaging, Dr Fahd Marafi, stressed the importance of molecular imaging as an extremely important method in diagnosis and obtaining information that other radiological imaging techniques do not provide and avoid medical procedures such as biopsies and surgeries.
Marafi said in a press statement on Sunday after the opening of the association’s annual conference that nuclear medicine and molecular imaging help doctors detect diseases in their early stages, even before symptoms appear. He explained that the conference organized by the Association discusses the latest developments locally and globally and is one of the most prominent scientific event of its kind in the region that brings together experts and researchers from across the world.
He said that the topics of the conference include diagnosis, treatment, nuclear applications, advanced clinical research, and the latest findings of nuclear medicine in artificial intelligence, in addition to presentations, workshops, and discussion sessions to exchange knowledge and build networks of professional relationships with the aim of raising the level of healthcare.
He explained that molecular medicine is involved in the diagnosis of all diseases and is an essential factor in determining the percentage of cancerous tumors and has a major role in treating some cancerous and non-cancerous conditions in the thyroid gland or prostate.
Chairman of the Council of Nuclear Medicine Departments and the Head of the Nuclear Medicine Department at the Kuwait Center Dr. Abdul Redha Abbas said the center is keen to keep up with the latest diagnostic and therapeutic methods for cancer patients and ensure that they comply with scientific recommendations and quality and safety standards.
He explained that nuclear medicine is a constantly developing field, “which impacts our understanding of diagnosis, treatment, and patient care,” considering that the conference is “an opportunity to enrich our knowledge and enhance innovation.” The collective commitment to pushing the boundaries of nuclear medicine will lead to directing healthcare for the better. — KUNA
